companies > G > GlaxoSmithKline GlaxoSmithKline Exelixis and GlaxoSmithKline to conclude six-year discovery and development collaboration 28 June 2008 Glaxo to cut 350 R&D jobs in drug research revamp 11 June 2008 GlaxoSmithKline, Daiichi in hypertension drug deal in India 14 May 2008 GSK Pharma signs licensing agreement with Astellas of Japan 05 May 2008 GlaxoSmithKline acquires Sirtris Pharmaceuticals 24 April 2008 US FDA approves Ranbaxy's generic version of GlaxoSmithKline's Ceftin for US sales 06 February 2008 Women’s Horlicks from GSK Consumer 30 January 2008 Ranbaxy announces settlement of possible Imitrex litigation with Glaxosmithkline 21 January 2008 GSK to launch cancer drug Tykerb in India 10 November 2007 Ranbaxy, GSK to settle valacyclovir patent case in US 26 July 2007 GlaxoSmithKline pharmaceuticals divests fine 26 July 2007 Ranbaxy-GSK alliance to develop respiratory drug 02 April 2007 Ranbaxy-Glaxo extend pact 07 February 2007 Glaxo moves court against Ranbaxy''s generic drug 03 February 2007 Glaxo buys Genmab's leukemia drug for record $2.1 billion 19 December 2006 Dr Reddy's to get generic rights as Glaxo settles Imitrex patent row 10 October 2006 GSK withdraws patent plea for AIDS drug Combivir 21 August 2006 GlaxoSmithKline Q2 net falls 12 per cent 27 July 2006 Ranbaxy acquires GlaxoSmithKline subsidiary Mundogen in Spain 18 July 2006 Ranbaxy to acquire Glaxo's generic business in Italy 28 March 2006 Oxford, GSK to partner in cancer research at leading clinical centres In India 17 October 2005 GSK makes a ''horlicks'' out its media meet 17 June 2005 GSK India announces buyback 15 March 2005 On the clinical trial trail 11 March 2005 GlaxoSmithKline to locate first Indian vaccine plant at Nashik 23 February 2005 GlaxoSmithKline Q4-05 up at 61.4% 17 February 2005 GSK sells worli plot for Rs107.6 crores 24 April 2004 GlaxoSmithKline, Burroughs Wellcome boards approve merger 18 March 2004 Horlicks gets new flavours 10 July 2003 GlaxoSmithKline announces a dividend of Rs 7 per equity share 13 March 2003 GlaxoSmithKline declares second interim dividend of 37% 21 December 2002 Glaxo SmithKline defers merger with Burroughs Wellcome 09 December 2002 Ranbaxy refutes Glaxo’s charge of stealing 24 August 2002 Glaxo SmithKline to sue Novartis, Ranbaxy 23 August 2002 GlaxoSmithKline interim dividend at 33% 31 July 2002 GlaxoSmithkline to launch new products 12 March 2002 Pharma sector fared well in 2001 28 December 2001 Pharma companies in talks with MIDC 13 December 2001 Iodex goes to SmithKline Healthcare 26 November 2001 GlaxoSmithKline''s plans for Affymax runs aground 31 July 2001 GlaxoSmithKline to sell-off Affymax 21 March 2001 GlaxoSmithKline strikes licensing deal with Merck 16 February 2001 Glaxo Wellcome, SmithKline Beecham agree to merge 17 January 2000 Large market share 17 January 2000 Why the merger worked this time 17 January 2000  search domain-b    go
Legal Policy | Copyright © 1999-2008 The Information Company Private Limited. All rights reserved.